Pharma Company Investment in Parenteral Manufacturing Capacity Picking Up

October 2, 2004

Jim Miller

Jim Miller

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Pharmaceutical Technology, Pharmaceutical Technology-10-02-2004, Volume 28, Issue 10

Big Pharma is ramping up capital spending in parenteral manufacturing at the same time that contract manufacturers are completing their own major investment programs.